Le Perray-en-Yvelines News (Ile de France, France)

tebu-bio is pleased to announce their agreement with CH3 BioSystems to distribute their product range to the European market.

Bromodomains are a new emerging class of pharmaceutical targets in the field of Epigenetics. Bromodomains (BRDs) are protein domains involved in Epigenetics that recognize acetylated lysines.

Stimulated Emission Depletion Microscopy (or STED nanoscopy) offers a technological breakthrough in the environment of cell imaging by drastically increasing the resolution over traditional confocal microscopy.

tebu-bio is pleased to announce their recent distribution agreement with Sanguine BioSciences, Inc.

tebu-bio is pleased to announce their agreement with CH3 BioSystems to distribute their product range to the European market.

Bromodomains are a new emerging class of pharmaceutical targets in the field of Epigenetics. Bromodomains (BRDs) are protein domains involved in Epigenetics that recognize acetylated lysines.

Stimulated Emission Depletion Microscopy (or STED nanoscopy) offers a technological breakthrough in the environment of cell imaging by drastically increasing the resolution over traditional confocal microscopy.

HypoThermosol® and CryoStor® Will Be Locally Available to the Broader European Research and Clinical Markets

tebu-bio and XenoTech LLC co-organize a series of webinars focused on attaching human hepatocytes in ADME-TOX studies.

The Kima™ pump is a microfluidic pump designed to aid cell culture (e.g. endothelial cells) under physiological conditions (shear flow) in various biochips and flow chambers.

tebu-bio is pleased to announce their recent distribution agreement with Sanguine BioSciences, Inc.

tebu-bio is pleased to be participating at the ELA Screening Europe conference which will take place in Hamburg from June 30th to July 1st, 2011

tebu-bio is pleased to announce the renewal for another three years, of their official recognition by the French Ministry of Higher Education & Research as an approved CRO (contract research organisation) within the French Research Tax Credit scheme.

tebu-bio is pleased to announce their recent distribution agreement with Cellix Ltd.

tebu-bio is pleased to announce the renewal of their agreement with Advanced Biotechnologies for the distribution of their products throughout Europe.

Since the launch of their first mini-website dedicated to SilenciX, tebu-bio has subsequently released sites focussed on Preadipocytes and Antibody Arrays, with the most recent addition now centered around CryostaX™.

tebu-bio will be attending the forthcoming ISNN congress "From reference intakes to personalized nutrition", which will take place in Pamplona, Spain, from November 18th to 20th, 2010.

tebu-bio (Le Perray en Yvelines, France) is pleased to enter an agreement with Arbor Assays LLC, (Ann Arbor, USA) for the distribution of their products to a large number of European countries.

tebu-bio is pleased to be attending the Hepatocyte User Group & Medicon Valley Hepatocytes User Forum which will take place in Montpellier, France, on October 22nd and 23rd 2010.

Constantly seeking to enrich their range of laboratory services, tebu-bio is now offering Life Sciences researchers a standardized protein expression optimisation service in E. coli.

tebu-bio has developped a new service entitled ExpressiX, bringing researchers the opportunity to obtain stable, ready-to-use cell lines with controlled, targeted gene integration.

LifeSensors and tebu-bio today announced that they have entered into an agreement under which tebu-bio will be LifeSensors' sole European distributor.

tebu-bio announces the launch of their new website, providing European Life Sciences Researchers with a powerful tool to help them in their research

tebu-bio (Le Perray en Yvelines, France) and Platypus Technologies (Madison, USA) are pleased to announce their agreement to have tebu-bio distribute the Platypus Oris™ kits throughout Europe.

Dr André Sobczyk (Protein Production Manager - tebu-bio), will be presenting the innovative protein production platform developed by tebu-bio laboratories at the Protein Congress 2008 in Berlin, on November 20th and 21st 2008.

tebu-bio, in partnership with SABiosciences (Frederick, MD), is pleased to announce the launch of SilenciX cell lines in the USA

Dr. Ali el Bayâ (Sales Manager - tebu-bio Germany) will be presenting SilenciX at the forthcoming 12th STS Meeting 2008: Signal Transduction – Receptors, Mediators and Genes, in Weimar (DE) from October 29th to 31st 2008.

tebu-bio is pleased to announce their laboratories have recently received official recognition from the French Ministry of Higher Education and Research as an approved CRO (contract research organisation) within the French Research Tax Credit scheme.

Nadia Normand (BioAssay Manager - tebu-bio Laboratories) will be presenting the SilenciX cell lines at the upcoming 5th annual RNAi Europe conference, which will be held from September 16th to 18th in Stockholm and is dedicated to RNA interference.

tebu-bio celebrates 10 years serving the ADME community in Paris in Autumn (October 9th, 2008; Maison de la Chimie, France).